NAD+ questions: safety, weight and legal status
A trial can answer a narrow question very well. The trouble starts when its answer travels to a different claim.
Is NAD+ safe to take daily?
The NR trial and the NMN trials reported good short-term tolerability in the people studied. The muscle study likewise reported no serious safety problems. Observation lasted weeks or months. Long-term safety remains unresolved, and the capsule findings leave compounded injection quality as a separate issue.
I attach greater evidentiary weight to observation length than to a broad “safe” label.
Does NAD IV therapy work?
Controlled evidence for lasting health benefit is thin. The IV pilot recorded metabolism and blood changes; it did not establish a general health benefit. The dosage page retains the route-specific persistence findings. The review of human precursor trials also shows why even repeated blood increases require clinical outcomes before they support larger health claims.
What is a NAD injection?
It delivers NAD+ by injection, bypassing the gut; an IV infusion delivers it directly into a vein. Subcutaneous and intramuscular injections have little firm pharmacokinetic research in the existing record. Compounded NAD+ for these treatments requires a prescription and has no FDA approval. The literature has not established a helpful personal injection schedule.
Weight change in NAD+ studies
The cited human precursor trials did not report weight gain. In the women’s NMN study, body composition stayed unchanged despite better muscle insulin sensitivity. Mice gained less age-associated weight after long-term NMN, but the human results establish neither a weight-loss treatment nor an expected change on the scales.
Does NAD+ make people look younger?
The cited human trials have not shown reversal of visible aging. Reports of lower NAD+ in older human tissues provide a biological reason to investigate aging. The broad intervention findings come chiefly from rodent experiments. The cosmetic promise seems to me assembled from incompatible pieces.
Does NAD+ help fertility?
Fertility is under investigation in cells and animals. The human trials in this reading list establish no fertility benefit. The human papers here test other outcomes. A trial measuring reproductive outcomes in people could address the fertility claim directly.
Is oral NAD+ effective?
Many positive blood results followed NR capsules or NMN capsules. Much swallowed NAD+ itself breaks down in the gut, and most cells take up whole NAD+ poorly. The metabolic distinction matters when a product and a trial use different ingredients.
Do NAD+ patches or nasal sprays work?
Controlled comparisons for patches, nasal sprays and preparations used beneath the tongue are sparse. Results from capsules or infusions cannot establish what those preparations deliver to tissues or whether they improve health. The delivery question needs direct testing.
NAD+ timing: morning versus night
NAD+ synthesis follows a daily rhythm, including changes in the salvage enzyme NAMPT described in the metabolism review. The trials cited here did not test timing as a variable. A biological clock supplies an interesting hypothesis; these studies supply no best-time instruction.
Duration of NAD+ side effects
Infusion-related symptoms in the research record resolved when infusions ended. Those observations cannot predict an individual reaction. Blood NAD+ returning toward baseline over weeks after precursor cessation is a different finding about persistence, discussed on the study amounts page.
Is NAD+ FDA-approved?
NAD+ has no FDA approval to prevent, treat or cure disease. Compounded NAD+ medicines have no FDA approval either. A prescription decision and FDA approval answer different questions.
Is NMN legal as a supplement?
The earlier FDA position excluded NMN from the dietary-supplement definition because it had been investigated as a drug before supplement use. The study list contains no later FDA decision resolving current sales status. WADA does not prohibit NAD+, NMN, NR or nicotinamide; that sports rule cannot settle supplement sales. The NMN page gives the dispute its context.